Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2013-10-18 AGM Information
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
AGM Resolutions passed 17 October 2013
AGM Information Classification · 99% confidence The document explicitly states it contains 'RESOLUTIONS' passed at an 'Annual General Meeting of the Company duly convened and held on Thursday 17th October 2013'. It details Ordinary and Special Resolutions concerning the approval of incentive plans, authorization for directors to allot securities, and authority for market purchases of shares. This content is characteristic of the formal documentation presented or passed during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2013-10-18 English
Trading Update and Board Changes
Earnings Release Classification · 99% confidence The document is titled 'Trading Update and Board Changes' and explicitly states it is an 'unaudited Interim Management Statement covering the period from 1 July 2013 to the date of this announcement. The financial reporting period covers the first quarter to 30 September 2013.' This content—a comprehensive update on quarterly performance and management changes—aligns perfectly with the definition of an Interim/Quarterly Report (IR). Although it mentions the AGM, the primary focus is the financial trading update for the quarter. The RNS Number (7032Q) and the 'END' marker suggest it was disseminated via a regulatory news service, but the content itself is the report, not just an announcement of the report's publication (RPA/RNS). Q1 2014
2013-10-17 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1880 characters) and is explicitly marked with an 'RNS Number'. The content details the total number of issued ordinary shares with voting rights (87,207,263) as of the announcement date (October 1, 2013), referencing compliance with DTR 5.6.1R (Disclosure and Transparency Rules). This type of notification, concerning the total voting rights denominator, is a standard regulatory disclosure often disseminated via the Regulatory News Service (RNS). While it relates to share capital, it is a notification about the total count rather than a transaction (POS) or a general capital change announcement (SHA). Given the RNS header and the nature of the disclosure (total voting rights), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such mandatory market disclosures that don't fit a more specific transactional code.
2013-10-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 98% confidence The document is identified by the RNS Number (RNS Number : 2648P) and contains an announcement regarding shareholding changes involving a Director/PDMR (Chief Financial Officer, Anne-Francoise Nesmes). Specifically, it details the granting of 'Nil cost option' awards over ordinary shares. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the Director's Dealing category.
2013-09-30 English
Additional Listing
Share Issue/Capital Change Classification · 99% confidence The document is very short (1896 characters) and explicitly states it is an 'RNS Number' announcement from 'Dechra Pharmaceuticals PLC' dated September 18, 2013. The content details an 'Additional Listing' application for 211,000 ordinary shares reserved under various employee share schemes (SAYE, Share Option Schemes). This is a specific regulatory announcement regarding the issuance of shares and admission to trading, which fits the description of a general regulatory filing or announcement. Since it is not a full report (like 10-K or IR) but a specific, short notice filed via RNS, the most appropriate classification is RNS (Regulatory Filings) as a general announcement category, although 'SHA' (Share Issue/Capital Change) is also highly relevant. Given the explicit 'RNS Number' header and the nature of the announcement (listing admission), RNS is a strong fit, but SHA describes the underlying corporate action. Since the document is a formal notification distributed via the RNS system detailing a capital change (new shares being admitted), SHA is more specific to the corporate action described (share issue/capital change). I will classify it as SHA due to the specific subject matter (block admission of shares for employee schemes), which is a form of capital change/share issue.
2013-09-18 English
Annual Financial Report - year ended 30 June 2013
Report Publication Announcement Classification · 99% confidence The document is very short (2131 characters) and explicitly states that the 'Annual Report and Accounts for the year ended 30 June 2013, Notice of Annual General Meeting and Proxy Form have now been posted to Shareholders.' It also mentions that these documents have been submitted to the National Storage Mechanism and are available on the company website. This structure—announcing the availability of primary reports (Annual Report, AGM Notice) rather than containing the full content of those reports—fits the definition of a Report Publication Announcement (RPA). Although it contains an RNS Number, the primary function described is the publication/posting of other documents.
2013-09-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.